MedTrace Logo

Longitudinal Monitoring of Inflammation in Cirrhosis

NCT05538962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2024-08-02

No results posted yet for this study

Summary

Longitudinal monitoring of inflammation using skin devices may help predict outcomes compared to traditional blood draws

Conditions

  • Cirrhosis, Liver

Interventions

DIAGNOSTIC_TEST

Sensor skin

Skin sensor to detect inflammatory molecules in sweat

Sponsors & Collaborators

  • Hunter Holmes Mcguire Veteran Affairs Medical Center

    lead FED

Principal Investigators

  • Jasmohan Bajaj, MD · Hunter Holmes McGuire VAMC

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-09-01
Completion
2024-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538962 on ClinicalTrials.gov